These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37675647)

  • 1. Angiogenic markers and maternal echocardiographic indices in women with hypertensive disorders of pregnancy.
    Giorgione V; Di Fabrizio C; Giallongo E; Khalil A; O'Driscoll J; Whitley G; Kennedy G; Murdoch CE; Thilaganathan B
    Ultrasound Obstet Gynecol; 2024 Feb; 63(2):206-213. PubMed ID: 37675647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripartum echocardiographic changes in women with hypertensive disorders of pregnancy.
    Giorgione V; O'Driscoll J; Coutinho CM; Di Fabrizio C; Sharma R; Khalil A; Thilaganathan B
    Ultrasound Obstet Gynecol; 2022 Mar; 59(3):365-370. PubMed ID: 34309939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.
    Palmrich P; Kalafat E; Pateisky P; Schirwani-Hartl N; Haberl C; Herrmann C; Khalil A; Binder J
    Ultrasound Obstet Gynecol; 2024 May; 63(5):619-626. PubMed ID: 37774098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
    Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of hypertensive disorders after screening at 36 weeks' gestation: comparison of angiogenic markers with competing-risks model.
    Schiattarella A; Magee LA; Wright A; Syngelaki A; Akolekar R; Von Dadelszen P; Nicolaides KH
    Ultrasound Obstet Gynecol; 2023 Sep; 62(3):345-352. PubMed ID: 37329494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for pre-eclampsia by maternal serum glycosylated fibronectin and angiogenic markers at 36 weeks' gestation.
    Sokratous N; Wright A; Syngelaki A; Kakouri E; Laich A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Jan; 63(1):88-97. PubMed ID: 37724582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midgestation cardiovascular phenotype in women who develop gestational diabetes and hypertensive disorders of pregnancy: comparative study.
    Anzoategui S; Gibbone E; Wright A; Nicolaides KH; Charakida M
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):207-214. PubMed ID: 35502146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
    Stepan H; Galindo A; Hund M; Schlembach D; Sillman J; Surbek D; Vatish M
    Ultrasound Obstet Gynecol; 2023 Feb; 61(2):168-180. PubMed ID: 35816445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses.
    Arechvo A; Wright A; Nobile Recalde A; Liandro R; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Mar; 63(3):358-364. PubMed ID: 37902727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
    Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal cardiac function at 19-23 weeks' gestation in prediction of pre-eclampsia.
    Gibbone E; Wright A; Vallenas Campos R; Sanchez Sierra A; Nicolaides KH; Charakida M
    Ultrasound Obstet Gynecol; 2021 May; 57(5):739-747. PubMed ID: 33294998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia.
    Akhter T; Wikström AK; Larsson M; Larsson A; Wikström G; Naessen T
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):93-99. PubMed ID: 27256927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should angiogenic markers be included in diagnostic criteria of superimposed pre-eclampsia in women with chronic hypertension?
    Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):192-201. PubMed ID: 34165863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal cardiovascular function in midgestation is related to placental angiogenesis.
    Papastefanou I; Szczepkowska A; Tezhaeva M; De Pauli M; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Aug; 64(2):180-186. PubMed ID: 38354267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sFlt-1/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19.
    Soldavini CM; Di Martino D; Sabattini E; Ornaghi S; Sterpi V; Erra R; Invernizzi F; Tine' G; Giardini V; Vergani P; Ossola MW; Ferrazzi E
    Pregnancy Hypertens; 2022 Mar; 27():103-109. PubMed ID: 34998223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher daytime systolic BP, prepregnancy BMI and an elevated sFlt-1/PlGF ratio predict the development of hypertension in normotensive pregnant women.
    Lara-Barea A; Sánchez-Lechuga B; Aguilar-Diosdado M; López-Tinoco C
    Reprod Biol Endocrinol; 2022 Dec; 20(1):175. PubMed ID: 36564806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of placental function correlate with prevalence and quantity of nucleated fetal cells in maternal circulation in normotensive term pregnancies.
    Fjeldstad HE; Jacobsen DP; Johnsen GM; Sugulle M; Chae A; Kanaan SB; Gammill HS; Staff AC
    Acta Obstet Gynecol Scand; 2023 Jun; 102(6):690-698. PubMed ID: 36933003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
    Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.